GlassScriptPhysician profile
Kenneth A Morris
NPI 1447220272
$6,249.00
in general payments reported to CMS, 2019-2025
38 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,315 · 2020: $1,309 · 2021: $1,160 · 2022: $830 · 2023: $494 · 2024: $709 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,619 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,619.43 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,027.36 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $850.10 | 2019-2025 | |
| Amgen INC. | $506.05 | 2019-2025 | Repatha, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $502.96 | 2019-2025 | Farxiga |
| Glaxosmithkline, LLC. | $358.21 | 2019-2023 | Arexvy, Shingrix |
| Amarin Pharma, INC. | $348.11 | 2019-2022 | |
| Lilly USA, LLC | $301.09 | 2019-2024 | Jardiance, Mounjaro |
| Pfizer INC. | $207.37 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $201.54 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $184.32 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $148.91 | 2019-2024 | |
| Kowa Pharmaceuticals America, INC. | $147.19 | 2019-2024 | Livalo |
| Merck Sharp & Dohme LLC | $138.78 | 2019-2022 | |
| Abbott Laboratories | $117.34 | 2021-2024 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $113.07 | 2020-2024 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.